CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 74 filers reported holding CYTOSORBENTS CORP in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,665,156 | -47.6% | 1,949,551 | 0.0% | 0.00% | – |
| Q2 2023 | $6,998,888 | +6.1% | 1,949,551 | -0.4% | 0.00% | – |
| Q1 2023 | $6,594,510 | +117.4% | 1,956,828 | 0.0% | 0.00% | – |
| Q4 2022 | $3,033,084 | +14.0% | 1,956,828 | +0.0% | 0.00% | – |
| Q3 2022 | $2,660,000 | -37.9% | 1,955,943 | 0.0% | 0.00% | – |
| Q2 2022 | $4,283,000 | -38.8% | 1,955,943 | -10.8% | 0.00% | – |
| Q1 2022 | $6,999,000 | -24.4% | 2,193,922 | -0.7% | 0.00% | – |
| Q4 2021 | $9,257,000 | -39.1% | 2,209,165 | +18.0% | 0.00% | – |
| Q3 2021 | $15,206,000 | -4.7% | 1,872,616 | -11.4% | 0.00% | – |
| Q2 2021 | $15,950,000 | -12.6% | 2,112,567 | +0.5% | 0.00% | – |
| Q1 2021 | $18,244,000 | +3.0% | 2,101,938 | -5.4% | 0.00% | -100.0% |
| Q4 2020 | $17,706,000 | +17.1% | 2,221,606 | +17.2% | 0.00% | 0.0% |
| Q3 2020 | $15,123,000 | -4.1% | 1,896,251 | +19.1% | 0.00% | 0.0% |
| Q2 2020 | $15,769,000 | +44.7% | 1,592,814 | +12.9% | 0.00% | – |
| Q1 2020 | $10,901,000 | +101.6% | 1,410,234 | +0.4% | 0.00% | – |
| Q4 2019 | $5,407,000 | -23.7% | 1,404,466 | -0.3% | 0.00% | – |
| Q3 2019 | $7,087,000 | -22.1% | 1,408,896 | +2.4% | 0.00% | – |
| Q2 2019 | $9,094,000 | -12.2% | 1,375,707 | +0.5% | 0.00% | – |
| Q1 2019 | $10,363,000 | -1.5% | 1,369,009 | +5.1% | 0.00% | – |
| Q4 2018 | $10,526,000 | -33.6% | 1,302,726 | +6.1% | 0.00% | -100.0% |
| Q3 2018 | $15,843,000 | +10.7% | 1,228,116 | -2.2% | 0.00% | 0.0% |
| Q2 2018 | $14,316,000 | +103.3% | 1,255,761 | +25.7% | 0.00% | – |
| Q1 2018 | $7,041,000 | +27.2% | 998,726 | +17.3% | 0.00% | – |
| Q4 2017 | $5,535,000 | +11.6% | 851,576 | +6.5% | 0.00% | – |
| Q3 2017 | $4,960,000 | +155.1% | 799,932 | +77.0% | 0.00% | – |
| Q2 2017 | $1,944,000 | -23.8% | 452,056 | -20.3% | 0.00% | – |
| Q1 2017 | $2,552,000 | -14.2% | 567,116 | +3.9% | 0.00% | – |
| Q4 2016 | $2,975,000 | -16.8% | 545,804 | -2.2% | 0.00% | – |
| Q3 2016 | $3,574,000 | +46.1% | 558,343 | +3.8% | 0.00% | – |
| Q2 2016 | $2,447,000 | +17.3% | 537,707 | +1.0% | 0.00% | – |
| Q1 2016 | $2,086,000 | -26.3% | 532,261 | +4.8% | 0.00% | – |
| Q4 2015 | $2,830,000 | -98.3% | 508,063 | -90.6% | 0.00% | -100.0% |
| Q3 2015 | $161,963,000 | +5424.0% | 5,397,469 | +1030.5% | 0.01% | – |
| Q2 2015 | $2,932,000 | -10.5% | 477,437 | +92.3% | 0.00% | – |
| Q1 2015 | $3,275,000 | – | 248,277 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |